Atalanta Sosnoff Capital’s Biogen BIIB Stock Holding History

Atalanta Sosnoff Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,400	Closed	-$848K	–	80
2018 Q3	$848K	Buy	+2,400	New	+$826K	0.03%	60
2016 Q2	–	Sell	-14,293	Closed	-$3.72M	–	107
2016 Q1	$3.72M	Buy	+14,293	New	+$3.78M	0.12%	80
2015 Q4	–	Sell	-38,835	Closed	-$11.3M	–	92
2015 Q3	$11.3M	Sell	38,835 -66,985	-63%	-$22.1M	0.36%	53
2015 Q2	$42.7M	Sell	105,820 -31,785	-23%	-$12.8M	1.17%	37
2015 Q1	$58.1M	Sell	137,605 -19,339	-12%	-$7.62M	1.55%	32
2014 Q4	$53.3M	Sell	156,944 -131,443	-46%	-$42.5M	1.31%	35
2014 Q3	$95.4M	Sell	288,387 -25,734	-8%	-$8.49M	2.36%	17
2014 Q2	$99M	Buy	314,121 +7,251	+2%	+$2.18M	2.17%	19
2014 Q1	$93.9M	Buy	306,870 +8,809	+3%	+$2.8M	2.09%	24
2013 Q4	$83.3M	Buy	298,061 +116,565	+64%	+$30.1M	1.8%	27
2013 Q3	$43.7M	Sell	181,496 -116,234	-39%	-$26M	1.15%	37
2013 Q2	$64.1M	Buy	+297,730	New	+$63.6M	1.55%	31

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atalanta Sosnoff Capital's BIIB Position: Q4 2018 in Review

Atalanta Sosnoff Capital sold out of Biogen (BIIB) in Q4 2018, closing a stake of 2,400 shares — an estimated $848K sold.

Atalanta Sosnoff Capital first reported a position in BIIB in Q2 2013 and held it in 12 quarters. The position peaked at $99M in Q2 2014. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Atalanta Sosnoff Capital reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Atalanta Sosnoff Capital sold 2,400 Biogen shares in Q4 2018, an estimated $848K.
Atalanta Sosnoff Capital first reported a position in Biogen in Q2 2013 and held it in 12 quarters.
Atalanta Sosnoff Capital's Biogen position peaked at $99M in Q2 2014.
1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Atalanta Sosnoff Capital's 13F filing for Q4 2018, filed 9 Jan 2019.